The Ministry of Public Administration has issued an official gazette notification confirming the contractual appointment of A.K.M. Ashrafuzzaman as the new Managing Director of Essential Drugs Company Limited (EDCL). This executive decision regarding the state-owned pharmaceutical manufacturer has generated significant debate within the ranks of the healthcare administration. The controversy stems from verified reports originating from both ministerial and institutional sources confirming that this strategic appointment was finalised without obtaining the statutory clearance or formal approval of the company’s governing board of directors.
The central government notification, formally dispatched by the Ministry of Public Administration, explicitly notes that A.K.M. Ashrafuzzaman has been assigned to the executive position for a specific tenure of one year. This has been executed under the legal provisions of Section 54(3) of the Memorandum and Articles of Association of Essential Drugs Company Limited, as governed by The Companies Act, 1994. According to the explicitly stated conditions of the state mandate, the newly designated chief executive must formally relinquish all commercial ties, professional practices, and employment contracts with any public, semi-government, autonomous, or private corporations prior to assuming office.
Procedural Anomalies and Official Reactivity
The official gazette states that the administrative directive has been executed in the public interest, with further specific terms and conditions of the service contract to be determined by a separate legal agreement. Following the prompt issuance of the state decree, A.K.M. Ashrafuzzaman formally submitted his official joining letter to assume his executive duties at the corporate headquarters of the state-owned pharmaceutical enterprise.
However, significant administrative anomalies have emerged regarding the publication and approval pipeline of this executive order:
Website Discrepancy: The formal notification regarding the managing director’s appointment could not be located on the official public database or website of the Ministry of Public Administration.
Ministerial Silence: When formally approached by journalists to clarify the administrative path of the appointment, the Minister of Health, Sardar Md. Sakhawat Hossain, explicitly declined to offer any comment or explanation regarding the decision.
Board By-Pass: Dr Ashrafi Ahmad, a prominent member of the EDCL board of directors and the Director General of the Directorate General of Family Planning, explicitly confirmed that the governing board was entirely bypassed.
Dr Ahmad noted that there was no agenda item regarding the appointment of a new managing director tabled during the most recent board assembly, concluding that the question of board endorsement simply does not arise.
Regulatory Protocol and Ministerial Departures
Senior administrative officials within the healthcare sector have expressed concern regarding the omission of standard legal procedures. Under the established regulatory framework governing state-owned enterprises, the appointment of a managing director requires the coordinated consensus of a specialised seven-member board of directors, which is structurally led by the Minister of Health. Following a formal board evaluation and vote, an official proposal is transmitted to the Ministry of Public Administration, which then proceeds to issue the required public gazette.
The implementation of this latest appointment took place whilst key members of the state’s healthcare leadership were away from the country. While Health Minister Sardar Md. Sakhawat Hossain serves ex-officio as the Chairman of the EDCL Board, two vital board directors—the State Minister for Health, Dr M.A. Muhit, and the Health Secretary, Md. Kamruzzaman Chowdhury—are currently on an official state visit to Geneva. Both senior officials are legally scheduled to return to Bangladesh on 1 June.
Workplace Unrest and Transitional Context
The sudden administrative transition follows a period of extreme operational volatility at the corporate offices of Essential Drugs Company Limited. Prior to this new directive, the position of managing director was occupied by Samad Mridha, who had been appointed by the interim government on 30 December 2024. His initial appointment had strictly adhered to regulatory protocols, citing the explicit approval of the 185th EDCL Board Meeting alongside Section 53(3) of the company’s Memorandum and Articles of Association.
| Official Managing Director | Date of Appointment | Governing Board Status | Legal Clause Cited |
| Samad Mridha | 30 December 2024 | Fully Approved (185th Session) | Section 53(3) of Articles |
| A.K.M. Ashrafuzzaman | Current Period | Omitted / No Board Agenda | Section 54(3) of Articles |
The transition of power was marked by significant unrest at the company’s Dhaka office. On the morning of the appointment, the corporate headquarters experienced a major security breach when a group of external individuals entered the premises and forcibly confined Samad Mridha along with several other senior corporate executives inside their offices. Law enforcement personnel were subsequently deployed to the scene, and police escorts were required to safely extract the besieged senior officials from the building.
When pressed for clarification regarding the legal and procedural basis of the accelerated appointment, multiple senior secretariat officials within the Ministry of Public Administration confirmed that the ministry had acted directly upon receiving a formal proposal and explicit instructions from the Prime Minister’s Office. The administrative officials stated that the ministry possessed no internal knowledge or jurisdiction regarding the internal procedural dynamics within the Ministry of Health and Family Welfare.